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In December 2013, the Public Health Policy 
Support Unit at the European Commission’s 
Joint Research Centre organised a two-day 
workshop on developing evidence-based 
guide lines and healthcare recommendations 
using GRADE.
GRADE stands for Grading of Recommenda-
tions Assessment, Development and Evaluation. 
It is a method for grading the quality of evi-
dence and going from this evidence to the 
corresponding healthcare recommendation.
The aims of the workshop were: 
• To explain how to develop evidence-based 
guidelines and health recommendations 
using the GRADE approach.
• To build a template for future trainings 
organised by the JRC on the guideline de-
velopment process.
Twenty participants, without experience using 
GRADE, attended the workshop–including 
14 JRC staff, as well as representatives from 
the Directorate General for Health and Con-
sumers (DG SANCO), the European Cen-
tre for Disease Prevention and Control 
(ECDC) and various external institutions. 
The workshop consisted of lectures on the 
theory behind guidelines development, group 
work and computer-based exercises.
Organisers and participants deemed the 
training a success and the Public Health 
Policy Support Unit is planning additional 
GRADE-oriented workshops in the future.
Executive summary
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DECIDE   Developing and Evaluating Communication Strategies
       to Support Informed Decisions and Practice Based on Evidence
DG RTD   Directorate-General Research and Innovation
DG SANCO  Directorate-General for Health and Consumers
EC      European Commission
ECDC    European Centre of Disease Prevention and Control
ECIBC    European Commission’s Initiative on Breast Cancer
EFSA     European Food Safety Authority
GRADE    Grading of Recommendations Assessment, Development and Evaluation
IHCP     Institute for Health and Consumer Protection
IOM     Institute of Medicine
JRC      Joint Research Centre
PHPS     Public Health Policy Support
RCT     Randomised Controlled Trial
List of acronyms and abbreviations
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The aims of the workshop were: 
• To explain how to develop evidence-based 
guidelines and health recommendations 
using the GRADE approach.
• To build a template for future trainings 
organised by the JRC on the guideline de-
velopment process.
The European Commission (EC) will develop 
the new European Guidelines for Breast Cancer 
Screening and Diagnosis (hereinafter referred 
to as the New European Guidelines) within the 
European Commission’s Initiative on Breast 
Cancer (ECIBC). The ECIBC is coordinated 
by the EC’s JRC, in particular by the Public 
Health Policy Support (PHPS) Unit 1 within 
the Institute for Health and Consumer Pro-
tection (IHCP).2
The JRC is building the methodological 
framework for developing the New European 
Guidelines. Consequently, there is a need to 
choose the most appropriate approach to 
1. http://ihcp.jrc.ec.europa.eu/our_activities/public-health.
2. http://ihcp.jrc.ec.europa.eu/.
grading evidence that could be potentially 
applied at all EC institutions involved in de-
veloping guidelines.
Although there are a number of systems for 
grading evidence, GRADE, which stands 
for ‘Grading of Recommendations Assess-
ment, Development and Evaluation’[1], was 
the system chosen by the ECIBC for the 
development of the New European Guidelines 
and the system which was proposed to the 
ECIBC stakeholders. This report summarises 
a two-day workshop on GRADE held at 
JRC-Ispra on 11 and 12 December 2013.
1. Context of the workshop
2. Aims of the workshop
Group work and computer-based exercises 
were held after theoretical sessions. Meeting 
facilitators were available to give practical 
advice. For most of the exercises, adapted 
versions of the templates provided by the 
GRADE Working Group were used. For the 
Risk of Bias exercise, the standard materi-
als provided by Cochrane Training 3 were used 
and a randomised controlled trial (RCT) 
was simulated, which allowed participants 
to discuss issues of study design and identify 
methods to minimise bias.
3. Cochrane Training (http://training.cochrane.org/) is an initia-
tive of The Cochrane Collaboration that covers all aspects of training 
related to the preparation and production of Cochrane reviews.
Invitations and selection of participants
This workshop was initially conceived as an 
internal training for the JRC PHPS Unit. 
However, workshop organisers considered 
that other colleagues and stakeholders could 
also benefit from the training. Therefore, in-
vitations were sent to:
• JRC PHPS Unit staff
• Staff from other EC institutions: 
– DG Health and Consumers (DG SANCO)
– DG Research & Innovation (DG RTD)
• Staff from European Union Agencies:
– The European Food Safety Authority 
(EFSA)
– The European Centre of Disease Pre-
vention and Control (ECDC)
• Individuals experts.
Participants
20 participants attended the workshop, none 
of whom had experience with GRADE. Four-
teen participants worked at the JRC, three at 
DG SANCO, one at the ECDC, and two par-
ticipants were from other non-EC institutions.
3. Workshop methods
4. Organisation of the workshop
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Facilitators
Jesús López Alcalde
Scientific/Technical project officer
European Commission
Joint Research Centre
IHCP 
PHPS Unit–Healthcare Quality Team 
+39 0332 78 3719
Jesus.Lopez-Alcalde@ec.europa.eu
• M.D. 
• Specialist in preventive medicine, epidemiology and public health
• Master of public health
• Experienced in systematic reviews, guidelines and conducting 
literature searches
Carlos Martín Saborido 
Scientific/Technical project officer
European Commission
Joint Research Centre
IHCP 
PHPS Unit–Nutrition and Health team
• BA in physiotherapy
• MSc in health economics
• MSc in health law
• MSc in health policy
• Ph.D. in biomedical sciences
• Experienced in health technology assessment (HTA)  
and economic evaluation
Juan Antonio Blasco Amaro
Scientific/Technical project officer
European Commission
Joint Research Centre
IHCP 
PHPS Unit–Medical Devices Task Force 
+39 0332 78 9210
juan-antonio.blasco-amaro@ec.europa.eu
• M.D. 
• Specialist in preventive medicine, epidemiology and public health
• Master of public health, health economics and health services 
management
• Experienced in HTA, guidelines and patients decision aids
Theodora Mouratidou
Scientific/Technical project officer
European Commission
Joint Research Centre
IHCP 
PHPS Unit–Nutrition and Health team
+39 0332 78 5343 
Theodora.Mouratidou@ec.europa.eu 
• Nutritionist
• Specialist in dietary assessment, epidemiology and public health
• MSc in human nutrition
• Ph.D. in dietary assessment
• Experienced in childhood and adolescent obesity, dietary assess-
ment methodology and energy balance-related behaviors
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5. Content of the workshop
The facilitators explained how to develop 
evidence-based guidelines and health recom-
mendations using GRADE. The participants 
were guided through the following processes:
• overview of the general process to devel-
op evidence-based guidelines
• formulation of the questions to be an-
swered in the guideline
• identification of patient relevant outcomes
• evaluation of the quality of evidence
• moving from the evidence to the recom-
mendation
• using the Guideline Development Tool. 4
The contents of the workshop are summa-
rised below.5
Introduction: Guideline development  
process and the GRADE approach
Facilitator: Jesús López Alcalde–JRC
A guideline is a document that focuses on 
a disease or condition and includes recom-
mendations for appropriate management of 
patients with this disease or condition. The 
guideline should be based on the best avail-
able evidence and should help healthcare 
providers by supplementing their knowl-
edge and skills. Guidelines can be tailored 
4. http://www.guidelinedevelopment.org/.
5. The agenda, presentations, and bibliography of the workshop 
are available at JRC-IHCP-Cancer Policy Support webpage: 
http://ihcp.jrc.ec.europa.eu/our_activities/public-health/cancer_
policy_support/presentations-from-the-grade-workshop-are-now-
available.
to clinical settings, health policy, health sys-
tems or public health [2, 3].
The workshop covered the criteria suggested 
by the Institute of Medicine (IOM) for con-
sidering a guideline as trustworthy [4]. Ac-
cording to the IOM, a guideline should:
• be based on a systematic review of exist-
ing evidence
• be developed by a knowledgeable, mul-
tidisciplinary panel of experts and repre-
sentatives from key affected groups
• consider important patient subgroups and 
patient preferences
• be based on an explicit and transparent 
process that minimises biases and con-
flicts of interest
• provide a clear explanation of the rela-
tionships between alternative care op-
tions and health outcomes
• be reconsidered and revised as appropriate.
The full guideline development process, from 
the recruiting of the guideline panel (the 
team developing the guideline) to imple-
mentation and updating was explained and 
some relevant organisations involved in de-
veloping guidelines, such as Guidelines Inter-
national Network (GIN),6 AGREE Trust 7 and 
GRADE Working Group 8 were mentioned.
6. http://www.g-i-n.net/.
7. http://www.agreetrust.org/.
8. http://www.gradeworkinggroup.org/.
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Framing a clinical question  
with the PICO format
Facilitator: Jesús López Alcalde–JRC
A guideline attempts to answer relevant 
questions related to the guideline topic. The 
facilitator described the different types of 
questions that a guideline developer may 
face and explained how to formulate ques-
tions in terms of:
• population (P),
• alternative options (an intervention (I) and 
a comparator (C)), and
• all outcomes that are important to patients 
and relevant stakeholders (O).
Choosing outcomes: the relative  
importance of outcomes
Facilitator: Jesús López Alcalde–JRC
Participants were informed about how to se-
lect outcomes and how to classify them as 
‘critical’, ‘important but not critical’ or ‘not 
important’ as regards the citizen, patient or 
other relevant stakeholder that will be af-
fected by the recommendation. Moreover, 
the participants were guided through an 
exercise to formulate the question ‘Should 
parenteral anticoagulants versus placebo or 
no intervention be used in patients with 
cancer with no indication for anticoagula-
tion?’ (see exercise here: JRC-IHCP-Cancer 
Policy Support web-page).
Study designs
Facilitator: Theodora Mouratidou–JRC
Guideline developers should consider study 
designs that are likely to provide reliable data 
for each guideline question. The facilitator 
explained what a study design is, the differ-
ences between experimental and observation-
al designs, and the study designs of choice 
for each research question. Because the work-
shop focused on guidelines about the effects 
of healthcare interventions, the study design 
of choice was the RCT, as randomisation is 
the only way to prevent systematic differ-
ences between baseline characteristics of par-
ticipants in different intervention groups in 
terms of both known and unknown (or un-
measured) confounders [5].
Finally, the facilitator ran an exercise to en-
sure that participants had a good understand-
ing of each type of study design.
Search of the literature
Facilitators: Theodora Mouratidou  
and Carlos Martín Saborido–JRC
Participants learned that evidence-based rec-
ommendations must be based on exhaustive 
search strategies that allow the identification 
of relevant evidence related to each critical 
or important outcome [6]. The facilitator pro-
vided information on where to search for evi-
dence (e.g. MEDLINE and other sources) and 
how to create search strategies with Boolean 
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operators,9 truncations,10 controlled vocab-
ulary and free terms, etc. In addition, a 
number of PubMed functionalities, such as 
My NCBI 11 were demonstrated. Finally, the 
participants carried out a practical exercise.
Determinants of QoE (I): risk of bias
Facilitator: Jesús López Alcalde–JRC
The GRADE Working Group interprets the 
word evidence as ‘confidence in the esti-
mates of the effect as provided by research’ 
and suggests a two-step process for rating its 
quality (or certainty):
1st step: rate the overall quality of the evi-
dence (QoE) for each outcome across studies
Table 1. Levels of certainty of the evidence.13
9. Boolean operators (AND, OR, NOT) link concepts and are 
used to broaden or narrow the search strategy.
10. Truncation can be used when you want the search engine to 
find all terms that begin with a given text string. Truncation is rep-
resented by the asterisk (*), sometimes referred to as a ‘wildcard’ in 
PubMed (http://goo.gl/1GAR0e).
2nd step: rate the overall QoE for the rec-
ommendation across all outcomes.
GRADE acknowledges that QoE may dif-
fer across outcomes and explicitly addresses 
this issue [7]. The workshop participants 
were trained on how to rate the QoE as de-
fined by GRADE.
Then, the session focused on the risk of bias, 
one of the factors to downgrade the QoE for 
a given outcome [5]. In order to clarify the 
concept of risk of bias, participants were in-
vited to participate to an interactive exercise 
designed by Cochrane Training 12. During the 
exercise a randomised controlled trial (RCT) 
was simulated, which allowed discussion of 
issues related to study design and identify 
methods to minimise the risk of bias.13
11. http://www.ncbi.nlm.nih.gov/myncbi/.
12. Cochrane Training (http://training.cochrane.org/) is an initia-
tive of The Cochrane Collaboration that covers all aspects of training 
related to the preparation and production of Cochrane reviews.
13. Adapted from the DECIDE Project: http://www.decide-col-
laboration.eu/WP5/Strategies/Framework.
Levels of certainty of the evidence Definitions
High This research provides a very good indication of the likely effect. 
The likelihood that the real effect will be substantially different from the effect 
provided by research is low.
Moderate This research provides a good indication of the likely effect.
The likelihood that the real effect will be substantially different from the effect 
provided by research is moderate.
Low This research provides some indication of the likely effect. 
However, the likelihood that the real effect will be substantially different from 
the effect provided by research is high.
Very Low This research does not provide a reliable indication of the likely effect. 
The likelihood that the real effect will be substantially different from the effect 
provided by research is very high.
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Determinants of QoE (II): indirectness
Facilitator: Jesús López Alcalde–JRC
Another factor to downgrade the QoE for a 
given outcome is indirectness [8]. GRADE 
considers that indirectness is due to:
• the presence of substantial differences be-
tween the population, intervention, or 
outcomes measured in the studies and 
those under consideration in the guideline 
being developed; or
• the absence of data for direct comparisons 
of the interventions addressed by the 
guideline (e.g. a recommendation aims to 
compare drug A versus drug B; however, 
data from RCTs directly comparing these 
two drugs are lacking, and the only avail-
able data are from RCTs comparing drug 
A to placebo and drug B to placebo). Ac-
cording to GRADE, such evidence would 
be downgraded due to indirectness.
Determinants of QoE (III): imprecision, 
inconsistency and publication bias
Facilitator: Juan Antonio Blasco Amaro–JRC
The facilitator explained that imprecision, 
inconsistency and publication bias are addi-
tional factors for downgrading the QoE for 
a given outcome. The facilitator explained 
how to interpret meta-analyses, forest plots, 
funnel plots and heterogeneity as well as 
highlighted that a meta-analysis should only 
be done under certain circumstances.
Determinants of QoE (IV): factors  
to upgrade the QoE
Facilitator: Carlos Martín Saborido–JRC
The facilitator explained that GRADE con-
siders certain criteria for upgrading the QoE 
for a given outcome including:
• a large magnitude of effect
• the presence of a dose-response relation-
ship
• issues related to confounding (e.g. all 
plausible confounders or biases would 
decrease an apparent treatment effect, or 
would create a spurious effect when re-
sults suggest no effect).
GRADE offers the possibility of upgrading 
the QoE initially assigned according to the 
study design.14 This approach may be espe-
cially useful in areas where RCTs are scarce 
and observational studies frequent, such as 
public health or healthcare quality and safe-
ty, as it allows considering the evidence pro-
vided by observational studies.
Going from the evidence  
to the recommendation
Facilitators: Jesús López Alcalde  
and Carlos Martín Saborido–JRC
Participants learned how GRADE separates 
the rating of the QoE from the rating of the 
strength of the recommendation and how 
the GRADE framework helps a guideline 
panel move from the evidence to the clini-
14. Traditional systems to grade the evidence considered the qual-
ity of evidence arising from RCTs always as ‘high’ and evidence 
from observational studies as ‘low’.
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cal recommendation. In addition, the par-
ticipants were guided through two primary 
aspects of this process:
• defining the direction of the recommendation 
(‘recommend for’ or ‘recommend against’ 
an option)
• grading the strength of the recommendation 
(‘strong recommendation’ or ‘weak rec-
ommendation’).
The strength of the recommendation reflects the 
extent to which a guideline panel is confi-
dent that the desirable effects of following 
a recommendation outweigh the potential 
undesirable effects. Its interpretation varies 
depending on who will use the recommen-
dation or guideline [9]:
Table 2. Meaning of the strength of the recommendation.
According to GRADE, a panel must consider 
factors besides the QoE when developing 
a recommendation. Therefore, high QoE 
will not always imply a strong recommenda-
tion while low QoE could imply a strong 
recommendation (if a number of factors are 
fulfilled). Again, this approach can be espe-
cially useful in areas where RCTs are scarce 
and observational studies frequent, such as 
public health.
Using the Guideline Development Tool 
(GDT) software
Facilitator: Jesús López Alcalde–JRC
The facilitators guided the participants in 
using the GRADE-DECIDE guideline de-
velopment tool (GDT) which allows the 
management of the whole guideline devel-
opment process. The tool is freely available 
at: http://www.guidelinedevelopment.org/.
According to its developers, the GDT is an 
easy to use, all-in-one web solution for sum- 
marising and presenting information for 
healthcare decision-making. It supports cre-
ating concise summary tables for systematic 
reviews and health technology assessments as 
well as facilitates the development of clinical 
practice guidelines and recommendations in 
public health or health policy decisions.15
15. http://www.guidelinedevelopment.org/.
Strength of the 
recommendation
Meaning for clinicians or patients Meaning for policy makers
Strong The panel believes that all or almost all 
informed people would choose the recom-
mended choice of action.
The panel believes that the recommenda-
tion can be adopted as a policy in most 
situations.
Weak (conditional) The panel believes that most informed people 
would choose the recommended choice of  
action, but a substantial number would not.
The panel believes that policy making will 
require substantial debate and involvement 
of many stakeholders.
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Participants’ feedback was collected and 
evaluated in order to determine satisfaction 
with the event and to identify areas for im-
provement. The feedback form covered the 
event’s preparation, delivery, organisation, 
logistics as well as an overall evaluation of 
the workshop. The results of this evalua-
tion will be carefully considered by the JRC 
in the planning and organisation of future 
workshops.
Summary of the workshop evaluation
In order to increase the response rate, a spe-
cific time on the final day of the workshop 
was allocated for completion of the feed-
back form. Eighteen out of the 20 partici-
pants completed the form (corresponding 
to 90% response rate). Likert scale items 
(‘below expectations’, ‘met expectations’, 
‘above expectations’, ‘not applicable’) are 
reported below as aggregate percentages. 
A full list of the participants’ comments is 
available upon request.
6. Workshop evaluation
Above expectations  Met expectations  Below expectations  Not applicable
Overall evaluation
Organisation and logistics
Programme
Contents, quality of presentations
Discussions time / 
interaction between participants
Exercises
Balance between sessions
Supporting material
Provision of additional resources
100%90%80%70%60%50%40%30%20%10%0%
78%
56%
72%
89%
66%
44%
39%
56%
44%
22%
39%
28%
11%
28%
50%
55%
44%
44%
6%
6%
6%
6% 6%
5%
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The JRC organised a workshop on the 
guide line development process. It aimed 
to explain how to develop evidence-based 
guidelines and health recommendations us-
ing the GRADE approach, and to build a 
template for possible future trainings.
The training was deemed a success as sug-
gested by participant feedback.
The Public Health Policy Support Unit would 
like to thank the GRADE Working Group for 
the materials provided, in particular the gen-
erous support provided by Professor Holger 
Schünemann, and the technical team of the 
Guideline Development Tool (GDT). 
We are also grateful to Cochrane Training, an 
initiative of The Cochrane Collaboration that 
covers all aspects of training related to the 
preparation and production of Cochrane 
reviews, for their assistance and supply of 
materials for the Risk of Bias exercise.  
The authors would like to acknowledge the 
fundamental support of Brigitte Westrit­
schnig, Chiara Margagliano, Elena Moneta 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and Marie Oskarsson for the organisation 
of the workshop.
In addition, we are grateful to Sabrina Gio­
ria and Pablo Mendoza for reviewing this 
report.
And finally, but not least, the authors are 
grateful to the participants for their ques-
tions and comments.
For further information about this work-
shop or future events, please contact:
jrc-cancer-policy-support@ec.europa.eu
The JRC will organise workshops with the 
same format dedicated to stakeholders in-
volved in developing guidelines, such as the 
working group that will develop the new 
Euro pean Guidelines for breast cancer screening 
and diagnosis.
The workshop materials are available for 
download in PDF format on the JRC-IHCP 
website:
• Agenda 
• Presentations, bibliography and exercises.
7. Conclusions
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Annex: Participant feedback form
Dear participant, please take a few minutes to fill out this feedback form. It will help us to assess how well this event 
met your expectations and will contribute to the improvement of future initiatives. Many thanks for your contribution.
Event’s preparation Below 
expectations
Met 
expectations
Above 
expectations
N/A
Programme
Objectives
Event’s delivery Below 
expectations
Met 
expectations
Above 
expectations
N/A
Contents, quality of presentations
Discussion time / interaction between participants
Exercises
Balance between sessions 
Speakers performance
   Jesús López Alcalde
   Theodora Mouratidou
   Juan Antonio Blasco Amaro
   Carlos Martín Saborido
Supporting material
Provision of additional resources  
(useful links, downloads, contacts)
Organisation and Logistics Below 
expectations
Met 
expectations
Above 
expectations
N/A
Organisation, location, communication with 
the participants, side events
General Comments Below 
expectations
Met 
expectations
Above 
expectations
N/A
Overall evaluation of the event
Any additional comment (especially for explaining 
the reasons for “below expectations”)
Event: GRADE Workshop
Date(s): 11-12 December 2013
Location: JRC-Ispra
Organiser: Public Health Policy Support
Participant’s name (optional):
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Abstract
The European Commission’s Joint Research Centre (JRC) organised a workshop on evidence-based guidelines development 
with GRADE (‘Grading of Recommendations Assessment, Development and Evaluation’). GRADE is a method of grading the 
quality of the evidence and going from this evidence to the corresponding recommendation.
Twenty participants attended the workshop, none of whom had experience with GRADE. Fourteen participants worked at the 
JRC, three at the Directorate General for Health and Consumers (DG SANCO), one at the European Centre of Disease Preven-
tion and Control (ECDC), and two participants were from other non-European Commission institutions.
The workshop consisted of group work and computer-based exercises held after theoretical sessions. Meeting facilitators 
were available to give practical advice. 
The training was deemed a success as suggested by participants’ feedback. The JRC will organise workshops with the same 
format dedicated to stakeholders involved in developing guidelines, such as the team of the new European Guidelines for 
breast cancer screening and diagnosis.
For further information about this workshop or future events, please contact: jrc-cancer-policy-support@ec.europa.eu
JRC Mission
As the Commission’s
in-house science service,
the Joint Research Centre’s
mission is to provide EU
policies with independent,
evidence-based scientific
and technical support
throughout the whole
policy cycle.
Working in close
cooperation with policy
Directorates-General,
the JRC addresses key
societal challenges while
stimulating innovation
through developing new
methods, tools and
standards, and sharing
its know-how with
the Member States,
the scientific community
and international partners.
Serving society
Stimulating innovation
Supporting legislation
LB-N
A-26958-EN
-N
doi:10.2788/458265
ISBN 978-92-79-44414-2
